This study is in progress, not accepting new patients
An Extension Study of JR-171-101 Study in Patients With MPS I
Summary
- Location
- at UCSF
- Dates
- study startedcompletion around
- Principal Investigator
- by Paul Harmatz (ucsf)
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at University of California Health
- Paul Harmatz (ucsf)
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- JCR Pharmaceuticals Co., Ltd.
- ID
- NCT04453085
- Phase
- Phase 1/2 research study
- Study Type
- Interventional
- Participants
- About 14 people participating
- Last Updated